Over 10,000 UK Breast Cancer Patients Could Become Eligible Within,the Next Year for a Breast Cancer Therapy Showing Increased,Survival Rates, Reveals Synovate Healthcare’s European,Oncology Monitor
LONDON April 4 2007--Treatment data fromSynovate Healthcare’s European Oncology Monitor reveals thatover 10000 breast cancer patients in the UK could become eligiblefor a breast cancer treatment showing lower death rates inpatients. The treatment was the subject of a recent study detailedin the online edition of The Lancet (12 February 2007). Lowermortality rates wer
LONDON, April 4, 2007--Treatment data from
Synovate Healthcare’s European Oncology Monitor reveals that
over 10,000 breast cancer patients in the UK could become eligible
for a breast cancer treatment showing lower death rates in
patients. The treatment was the subject of a recent study detailed
in the online edition of The Lancet (12 February 2007). Lower
mortality rates were shown in patients who had switched to the
aromotase inhibitor, Aromasin (exemestane), after 2-3 years of the
current standard hormone drug therapy, tamoxifen. Aromasin was
recently approved by the National Institute for Clinical Excellence
(NICE).
Patients who could be eligible in this new
indication were defined as newly diagnosed women in early stage
disease who test positive for markers indicating hormone therapy as
a treatment option, as well as those who have been on tamoxifen for
3 years or less. According to Synovate Healthcare’s data, 80%
of drug-treated patients diagnosed in early stages are hormone
responsive. Types of hormone therapies include tamoxifen and three
aromatase inhibitors recently approved by the NICE. About 13% of
newly diagnosed early stage breast cancer patients receive
tamoxifen therapy in the UK annually.
Cancer Research UK and Globocan statistics from the
World Health Organisation suggest that over 40,000 cases of breast
cancer are diagnosed in the UK each year. Synovate Healthcare data
shows that over 23,000 newly diagnosed patients are treated with
drug therapies. Using data on the number of newly diagnosed women
in early stage disease, together with the number of existing
patients on tamoxifen, Synovate Healthcare estimates that over
10,000 breast cancer patients in the UK could become eligible for
this new treatment within the next year.
Leah Krukowski, Head of Synovate Healthcare’s
European Oncology Monitor, commented, “It is encouraging to
see how many peoples&
'"/>
Page: 1 2 3 Related medicine technology :1.
Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy2.
Study Shows Ixabepilone Demonstrated Clear Activity in Patients
with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,
and Capecitabine3.
Peer Reviewed Journal Article Indicates Repros Proellex Exhibits
Potential for New Approach to the Treatment and Prevention of
Breast Cancer4.
Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast
Cancer Risk Prediction in Women with Atypia5.
Allos Therapeutics Reports Results for Phase 3 Enrich Study of
Efaproxyn in Women With Brain Metastases Originating From Breast
Cancer6.
Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal
Women with Early Breast Cancer Receiving Treatment with Tamoxifen7.
Women Well-Informed About Breast Cancer, Yet Lacking Knowledge
About Current Treatments, New Survey Finds8.
Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer
Study Presented at ASCO9.
New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly
Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer
Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by
Paclitaxel10.
Caelyx Delays Time to Disease Progression as Maintenance Therapy in
Patients with Metastatic Breast Cancer11.
Updated Overall Survival Data From Pivotal Herceptin Adjuvant
Studies in HER2-Positive Breast Cancer
(Date:5/16/2013)... , May 16, 2013 Alere Inc. (NYSE: ... charge of their health at home through the merger of ... of $3.00 per share on its Series B Convertible Perpetual ... 15, 2013 to holders of record of Series B stock ... Such payment will cover the amount of all dividends ...
(Date:5/16/2013)... JACKSONVILLE, Florida , May 16, 2013 ... private practice in the U.S. to access the widely-used ... just a PC and Internet connection to get started. ... pre-operative planning software for over 10 years, is dedicated ... to template with digital x-ray images, when printed film ...
(Date:5/16/2013)... PARK, N.J. , May 16, 2013 A ... that women living with vulvar and vaginal atrophy (VVA) ... chronic condition, or are simply dissatisfied with the therapies ... Women ,s VI ews of Treatment Options ... multiple barriers to the treatment of VVA, including lack ...
Breaking Medicine Technology:OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy 2New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy 3... , - Large, International REACH Registry ... Undertreated With Antiplatelet and Anticoagulant,Therapies, A ... have,atrial fibrillation (AF), greatly increasing their risk ... to new findings from the large,international REACH ...
... first and only participant in Texas for TFAS spinal implant, ... leading,the way again in motion preserving technology by continuing to ... Facet Arthroplasty,System (TFAS)(R)., Dr. Barton Sachs of Texas Back ... The Richardson, Texas resident was one of,the first 40 people ...
Cached Medicine Technology:Atrial Fibrillation Found to be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke 2Atrial Fibrillation Found to be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke 3Atrial Fibrillation Found to be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke 4Texas Back Institute Leads Way in New Facet Joint Clinical Trial 2(Date:5/18/2013)... May 18, 2013 The topics that will ... scrum framework, scrum roles, scrum meetings, scrum artifacts, and scrum ... PDUs) for attending them. , These trainings are suitable for ... also ideal for those who will be a part of ... who want to explore Agile and Scrum, but are unsure ...
(Date:5/18/2013)... 2013 Kimono condoms assorted sampler ... condom store recently announced. Condomania recently added new ... selection of condoms from all over the world. ... to try different condom styles from one of the ... classic comfortable shape and secure, the new packs contain ...
(Date:5/18/2013)... 2013 Medical device company, FlexLeg, LLC, last ... anticipated mobility aid with its namesake, the FlexLeg. The ... crutch alternative that injured individuals can use to walk ... can remain active and walk during a typical 6-8 week ... system to ensure those who need the device most are ...
(Date:5/18/2013)... 2013 The product liability attorneys at Wright ... behalf of consumers nationwide who have sustained serious tendon injuries ... These cases are all part of MDL 2308 and were ... will be heard in the U.S. District Court of ... & Schulte, LLC specializes in defending the rights of those ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Allen J. Schultz, ... gum disease treatment available to residents of San ... of the diseased tissue rather than relying on a scalpel ... FDA cleared laser that works on tightly defined wavelengths to ... and healthy tissue intact. , Only about one in every ...
Breaking Medicine News(10 mins):Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3Health News:Kimono Condoms Assorted Sampler Packs Now Available at Condomania 2Health News:FlexLeg Begins Offering New Mobility Aid 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 2Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 3Health News:Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups 4Health News:San Clemente, CA Periodontist, Dr. Allen J. Schultz, Now Provides Laser Gum Disease Treatment to Southern Orange County Periodontal Disease Patients 2... has come out with a warning to consumers and health care ... Teq, to infants. There is reportedly a risk of intussusception. ... months of age, in three doses as an optional vaccine to ... at times, fatal. , The reporting of 28 cases ...
... lung cancer has won $ 1 million in a lottery. Wayne ... inoperable lung cancer. ,Doctors have given him a year ... he has won this lottery. But the irony that is accompanying ... annual installments over twenty years. ,Schenk is a chain ...
... University in Chicago claim that men who have undergone ... type// of dementia. This study was published in Cognitive ... on 106 men. Out of this, 25 developed a ... undergone vasectomy. According to the chief scientist of this ...
... A new study suggests that patients who develop ... family history includes alcohol// abuse may be more ... effect of medications used to treat their condition. ... shopping, hypersexuality, binge eating and pathological gambling—have been ...
... sclerosis (MS) for 10 years and have few of the disabling ... and that their symptoms will likely not ever occur to the ... that unfortunately this may not be correct. ,After ... whose MS was benign at 10 years, according to the study. ...
... screening has increased, there are still significant disparities in ... of these disparities are by ethnicity, sex, age, education ... the third most common cancer affecting men and women ... in 2005, according to background information in the article. ...
Cached Medicine News:Health News:Compulsive Gambling Linked to Parkinson's Disease Medications 2Health News:Disparities in Colon Cancer Screening Remain Among Medicare Patients 2... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products:Biology NavigationMedical Navigation